20th International Congress » Parkinson's disease: Cognition

Date: Wednesday, June 22, 2016

Time: 12:00pm-1:30pm

Location: Exhibit Hall located in Hall B, Level 2

Session Type: Poster Session

Meeting: 20th International Congress

12:00pm-1:30pm: A proposed Parkinson’s disease neuropsychological battery (PNB)

L.L. van Wanrooij, J. Hoogland, J.G. Goldman, G. Stebbins, G.J. Geurtsen, D. Weintraub (Amsterdam, Netherlands)

12:00pm-1:30pm: A technological solution for monitoring Parkinson’s disease: A patient-based perspective on necessity, usability and acceptability

S. Couth, E. Poliakoff, J. Vega, C. Jay, S. Harper, R. Almutiry, T.F. Cootes, A.M. Ramsay, S.A. Kotz (Manchester, United Kingdom)

12:00pm-1:30pm: Analysis of factors associated with cognitive and functional performance in Parkinsonian with normal mini-mental state examination

R. Breder, M.A.A. Leite, M.C.A. Ribas, M. Orsini (Niterói, Brazil)

12:00pm-1:30pm: Apolipoprotein E genotypes in Brazilian patients with Parkinson’s disease and their correlation with cognitive performance assessed by MoCA

M.M.C.M. Brito, R.S.J. Silva, V. Tumas, I.F. Mata, C.Z. Zabetian (Ribeirão Preto, Brazil)

12:00pm-1:30pm: Apraxia in Parkinson’s disease

M. Tábuas-Pereira, P. Correia, F. Moreira, A. Morgadinho, C. Januário (Coimbra, Portugal)

12:00pm-1:30pm: Are limbic and cognitive effects on balance in Parkinson’s disease equal?

K.A. Ehgoetz Martens, C.G. Ellard, Q.J. Almeida (Camperdown, Australia)

12:00pm-1:30pm: Arterial spin labeling perfusion MRI compensate for other diagnostic tools in evaluation of Parkinson’s disease with dementia

K. Abe, T. Hayashi, N. Akiyama, M. Yamamoto, M. Fujita (Nishinomiya, Japan)

12:00pm-1:30pm: Assessment of humor in Parkinson’s disease and the effect of deep brain stimulation

A. Greuel, C.J. Lewis, F. Maier, R. Dano, S. Heintz, W. Ruch, C. Eggers (Cologne, Germany)

12:00pm-1:30pm: Association between cognitive status and mobility performance in dual task condition in patients with Parkinson’s disease

S.M.A.A. Pompeu, T.B. Freitas, K.G. Silva, C. Torriani-Pasin, F. Doná, J.E. Pompeu (São Paulo, Brazil)

12:00pm-1:30pm: Association between urine protein/creatinine ratio and cognitive dysfunction in Parkinson’s disease

Y.S. Oh, J.S. Kim, K.S. Lee (Seoul, Korea)

12:00pm-1:30pm: Association or causation? Orthostatic hypotension and cognitive impairment in α-synucleinopathies: A systematic review

S.J. Udow, A.E. Lang, M. Masellis (Toronto, ON, Canada)

12:00pm-1:30pm: Attention and dopamine: Increased distractibility in Parkinson’s disease

C. Warden, S. YorkWilliams, N. Ahn, D. Everling, K.L. Poston (Stanford, CA, USA)

12:00pm-1:30pm: Baseline physical activity may influence exercise-induced changes in cognitive function in Parkinson’s disease

R. Chow, C.R.A. Silveira, B.N. Intzandt, E. Beck, Q.J. Almeida (Waterloo, ON, Canada)

12:00pm-1:30pm: Catechol-o-methyltransferase Val158Met polymorphism influences prefrontal executive function in early Parkinson’s disease

Y. Zhang, Y. Zhang, K. Nie, S. Feng, L. Wang, J. Zhao, Z. Huang, L. Wang (Guangzhou, People's Republic of China)

12:00pm-1:30pm: Cerebrospinal fluid biomarkers in Parkinson’s disease and associated cognitive impairment

M. Delgado-Alvarado, B. Gago, A. Gorostidi, H. Jiménez-Urbieta, J. Ruiz-Martínez, A. Bergaretxe-Yarza, J.F. Martí-Massó, P. Martínez-Lage, A. Izagirre, A. Oregi, L. Sepúlveda, M.C. Rodríguez-Oroz (San Sebastián, Spain)

12:00pm-1:30pm: Characteristics of drop outs in a longitudinal study on individuals at risk for a neurodegenerative disorder

U. Suenkel, S. Heinzel, A.K. von Thaler, F. Metzger, G.W. Eschweiler, I. Liepelt-Scarfone, W. Maetzler, D. Berg (Tübingen, Germany)

12:00pm-1:30pm: Circulatory levels of BDNF correlate with cognitive deficits in people with Parkinson’s disease

H. Khalil, M.A. Alomari, O.F. Khabour, A. Al-Hieshan, J.A. Bajwa (Irbid, Jordan)

12:00pm-1:30pm: Cognition and amyloid biomarker status in non-demented patients with Parkinson’s disease patients (PD) with or without subjective cognitive decline (SCD)

I. Liepelt-Scarfone, F. Klumpp, W. Maetzler, S. Nussbaum, M. Timmers, G. Salvadore, M. Albers, K. Michaelis, Z. Tkaczynska, J. Streffer, D. Berg (Tübingen, Germany)

12:00pm-1:30pm: Cognitive and psychiatric outcome 3 years after bilateral deep brain stimulation of the globus pallidus pars interna versus subthalamic nucleus for Parkinson’s disease

J.A. Boel, V.J.J. Odekerken, G.J. Geurtsen, B.A. Schmand, M. Figee, R.J. de Haan, P. van den Munckhof, P.R. Schuurman, R.M.A. de Bie, The NSTAPS Study Group (Amsterdam, Netherlands)

12:00pm-1:30pm: Cognitive complaint in Parkinson’s disease patients with normal cognition

R.F. Purri, L. Brennan, J. Rick, L. Chahine, N. Dahodwala, A. Chen-Plotkin, J.E. Duda, J.F. Morley, R.S. Akhtar, J.Q. Trojanowski, D. Weintraub (Philadelphia, PA, USA)

12:00pm-1:30pm: Consolidation of learning and memory in Parkinson’s disease

M.E. Sharp, K. Duncan, K. Foerde, R. Kahane, D. Shohamy (New York City, NY, USA)

12:00pm-1:30pm: Construct validity of Moca test in a sample of patients with Parkinson´s disease in Bogotá and Cali – Colombia

B.E. Muñoz, O. Bernal, A. Castillo, J.L. Orozco (Cali, Colombia)

12:00pm-1:30pm: Cytokines in CSF and plasma as potential biomarkers for PD cognitive impairment

M. Delgado-Alvarado, B. Gago, A. Gorostidi, H. Jiménez-Urbieta, J. Ruiz-Martínez, A. Bergaretxe-Yarza, J.F. Martí-Massó, P. Martínez-Lage, A. Izagirre, A. Oregi, L. Sepúlveda, M.C. Rodríguez-Oroz (San Sebastián, Spain)

12:00pm-1:30pm: Decline in drawing ability associated with frontal dysfunction after subthalamic nucleus deep brain stimulation in Parkinson’s disease

S. Hirano, S. Furukawa, M. Asahina, T. Yamamoto, T. Uchiyama, Y. Yamanaka, Y. Higuchi, T. Horikoshi, T. Uno, N. Saeki, S. Kuwabara (Chiba, Japan)

12:00pm-1:30pm: Defective visual perception in patients with Parkinson’s disease: The impairment of preattentive visual processing in the normal intellectual patients

Y. Higashi, T. Tabuchi, M. Tabata, E. Mori (Himeji, Japan)

12:00pm-1:30pm: Does cognitive decline contribute to poorer quality of life in incident Parkinson’s disease? A three year follow up

R.A. Lawson, A.J. Yarnall, G.W. Duncan, D.P. Breen, T.K. Khoo, C.H. Williams-Gray, R.A. Barker, D. Collerton, J.P. Taylor, D.J. Burn (Newcastle upon Tyne, United Kingdom)

12:00pm-1:30pm: Does repetitive transcranial magnetic stimulation (rTMS) affect cognitive function in Parkinson’s disease by modulating high-frequency brain oscillations: A magnetoencephalography (MEG) study

I. Buard, J. Shattuck, B.M. Kluger (Aurora, CO, USA)

12:00pm-1:30pm: Dopamine modulates learning conflicting action-valence associations in Parkinson’s disease

N.C. van Wouwe, D.O. Claassen, J.S. Neimat, S.A. Wylie (Nashville, TN, USA)

12:00pm-1:30pm: Dopaminergic drug management in Parkinson’s disease: Gait and language function show correlation during treatment

H. Murakami, A. Futamura, T. Kuroda, S. Ishigaki, M. Kezuka, K. Ono, M. Kawamura (Tokyo, Japan)

12:00pm-1:30pm: Dyskinesias-reduced-self-awareness and theory of mind in Parkinson’s disease: A novel frame of interpretation

S. Palermo, M. Amanzio, M. Zibetti, L. Lopiano (Turin, Italy)

12:00pm-1:30pm: Effect of rivastigmine in Parkinson’s disease dementia – A logitudinal observational study

S. Raha, L. Ebenezer (Bridgend, United Kingdom)

12:00pm-1:30pm: Effects of a 12-week exercise program on cognition in Parkinson’s disease

J.C. Johnson, A.L. Svitak, M.T. Farrell, S.C. Mosch, F. Yu, E.D. Parker, L.R. Hanson (Saint Paul, MN, USA)

12:00pm-1:30pm: Effects of gender, age and hyposmia on cognitive functions in healthy elderly individuals at risk for Parkinson’s disease: Results from the TREND study

S. Heinzel, U. Suenkel, F.G. Metzger, E. Schaeffer, B. Roeben, R. Yilmaz, S. Lerche, K. Brockmann, A.K. von Thaler, I. Liepelt-Scarfone, G.W. Eschweiler, A.J. Fallgatter, W. Maetzler, D. Berg (Tübingen, Germany)

12:00pm-1:30pm: Executive function and verbal fluency in patients with Parkinson’s disease

A.F. Barbosa, M.C. Voos, C.O. Souza, J. Chen, H.F. Chien, D.V. Francato, E.R. Barbosa, L.L. Mansur (São Paulo, Brazil)

12:00pm-1:30pm: Eye tracking-based measurement of cognitive functions in patients with neurodegenerative diseases

H. Schmitz-Peiffer, K. Linse, W. Rüger, M. Joos, M. Löhle, A. Storch, A. Hermann (Dresden, Germany)

12:00pm-1:30pm: Fall prediction in Parkinson’s disease based on motor dual-tasking: Evidence from the prospective MODEP study

S. Heinzel, M. Maechtel, S.E. Hasmann, M.A. Hobert, T. Heger, D. Berg, W. Maetzler (Tübingen, Germany)

12:00pm-1:30pm: Functional connectivity during resting state in Parkinson’s disease patients with and without mild cognitive impairment

O. Monchi, A. Nagano-Saito, A. Hanganu, S. Jobert, B. Mejia-Constain, C. Degroot, A.L. Lafontaine, H. Chertkow, A. Tam, P. Orban, P. Bellec, O. Monchi (Calgary, AB, Canada)

12:00pm-1:30pm: Gait and cognition: Mapping the global and discrete relationships in ageing and neurodegenerative disease

R. Morris, S. Lord, J. Bunce, D. Burn, L. Rochester (Newcastle-Upon-Tyne, United Kingdom)

12:00pm-1:30pm: Genetic factors influencing frontostriatal dysfunction and the development of dementia in Parkinson’s disease

I. Huertas Fernandez, S. Jesus, F.J. Garcia Gomez, J.A. Lojo, I. Bernal Bernal, M. Bonilla Toribio, J.F. Martin Rodriguez, D. Garcia Solis, P. Gomez Garre, P. Mir (Sevilla, Spain)

12:00pm-1:30pm: Grey matter atrophy associated with the progression of cognitive decline in Parkinson’s disease (PD)

M. Chondrogiorgi, L.G. Astrakas, A.K. Zikou, M.I. Argyropoulou, S. Konitsiotis (Ioannina, Greece)

12:00pm-1:30pm: How do cognitive profiles differ in patients with Parkinson’s disease with cognitive decline in comparison to patients remaining cognitively stable? Preliminary results of a 3 years follow-up study

A. Meyer, U. Gschwandtner, V. Cozac, F. Hatz, P. Fuhr (Basel, Switzerland)

12:00pm-1:30pm: How does cognition affect reaching in Parkinson’s disease?

J. Cosgrove, C. Picardi, S.L. Smith, S. Jamieson, J.E. Alty (Leeds, United Kingdom)

12:00pm-1:30pm: Imitation of hand movements in Parkinson’s disease: A comparison with visual cueing

J. Bek, E. Gowen, S. Vogt, T. Crawford, E. Stack, J. Dick, E. Poliakoff (Manchester, United Kingdom)

12:00pm-1:30pm: Impact of behavioral side effects on the management of Parkinson patients treated with dopamine agonists

M.E. Mohammad, J.A. Vizcarra, K. O'Donnell, S. Patel, X. Garcia, X.X. Yu, K. Vlastaris, K. Sutton, H.H. Fernandez (Cleveland, OH, USA)

12:00pm-1:30pm: Impact of sociodemographic and clinical characteristics on cognition of individuals with Parkinson’s disease

M.R. Olchik, A. Ayres, M. Ghisi, A.F.S. Schuh, C.R.M. Rieder (Porto Alegre, Brazil)

12:00pm-1:30pm: Impaired cube copy on the MOCA indicates worse performance in several cognitive domains in Parkinson´s disease

C. Gasca-Salas, M. Cohn, J.A. Pineda, J.A. Obeso (Madrid, Spain)

12:00pm-1:30pm: Impairment of decision-making processes in patients with Parkinson’s disease during a strategic game

A.C. Parr, B.C. Coe, G. Pari, D.P. Munoz (Kingston, ON, Canada)

12:00pm-1:30pm: Interrelation between gait impairment with cognitive disturbances in patients with Parkinson’s disease

K. Stepanchenko (Kharkiv, Ukraine)

12:00pm-1:30pm: Investigating the relationship between reaction time and cognition in Parkinson’s disease

J. Cosgrove, C. Picardi, S.L. Smith, S. Jamieson, J.E. Alty (Leeds, United Kingdom)

12:00pm-1:30pm: Investigation of driving ability to drive safely in patients with Parkinson’s disease by interview

R. Ando, C. Yamazaki, H. Iwaki, H. Yabe, N. Nishikawa, M. Nagai, K. Nakashima, M. Nomoto, Safe Driving Study Group of Japan (Tohon, Japan)

12:00pm-1:30pm: Longterm outcome of cognition following subthalamic deep brain stimulation in Parkinson´s disease

D. Gruber, C. Lisa, A. Kuehn, U. Kopp, G.H. Schneider, A. Kupsch (Beelitz-Heilstätten, Germany)

12:00pm-1:30pm: Mild cognitive impairment in Parkinson’s disease: Impact on caregiver outcomes

J.Y.Y. Szeto, M. Gilat, C.C. Walton, L. Mowszowski, S.L. Naismith, S.J.G. Lewis (Sydney, Australia)

12:00pm-1:30pm: Neuro-cognitive domain related to conversion of Parkinson’s disease dementia

S.M. Cheon, S.Y. Lee, J.W. Kim (Busan, Korea)

12:00pm-1:30pm: Neuron specific protein S100B and cognitive impairment in various forms parkinsonism

R.J. Matmurodov, K.M. Khalimova, N.S. Rashidova, U. Ergashev, O. Turgunhojayev (Tashkent, Uzbekistan)

12:00pm-1:30pm: Neuropsychological subgroups in non-demented Parkinson’s disease: A latent class analysis

L. Brennan, K. Devlin, S.X. Xie, D. Mechanic-Hamilton, B. Tran, H. Hurtig, A. Chen-Plotkin, L. Chahine, J.F. Morley, J.E. Duda, D.R. Roalf, N. Dahodwala, J. Rick, J.Q. Trojanowski, P.J. Moberg, D. Weintraub (Philadelphia, PA, USA)

12:00pm-1:30pm: Occurrence and pattern of cognitive deficits in prodromal Parkinson’s disease

C. Pausch, J. Spiegel, F.A. Wollenweber, C. Bayer, U. Dillmann, K. Fassbender, S. Behnke (Homburg Saar, Germany)

12:00pm-1:30pm: Optic nerve integration as a visuospatial cognitive predictor in Parkinson’s disease

J.J. Lee, Y. Lee, S.J. Chung, Y.H. Sohn, P.H. Lee (Seoul, Korea)

12:00pm-1:30pm: Participation in cognitively-stimulating activities and computer use are associated with better cognitive performance in Parkinson’s disease independent from nigrostriatal dopaminergic and cortical cholinergic degenerations

J.L.B. Bohnen, M.L.T.M. Muller, J.D.J. Haugen, N.I. Bohnen (Ann Arbor, MI, USA)

12:00pm-1:30pm: Perception of time in music in Parkinson´s disease – Processing of musical syntax compensates rhythmic deficits

D. Bellinger, E. Altenmüller, J. Volkmann (Wuerzburg, Germany)

12:00pm-1:30pm: Performance in Montreal cognitive assessment and functional independence in Parkinsonian with normal mini-mental state examination

R. Breder, M.A.A. Leite, B.L. Pessoa, C.O. Vilaça (Niterói, Brazil)

12:00pm-1:30pm: Piperine potentiates neuroprotective effect of curcumin in MPTP model of Parkinson’s disease in rats: Impact on neurochemical modulation

S. Singh, P. Kumar (Moga, India)

12:00pm-1:30pm: Predictive performance of EEG theta spectral power over developing dementia in Parkinson’s disease

V.V. Cozac, M. Chaturvedi, U. Gschwandtner, F. Hatz, A. Meyer, K. Nowak, R. Sturzenegger, P. Fuhr (Basel, Switzerland)

12:00pm-1:30pm: Predictors of dementia in Parkinson’s disease: A population-based cohort study

A. Keener, K. Paul, A. Folle, J. Bronstein, B. Ritz (Los Angeles, CA, USA)

12:00pm-1:30pm: Rapid eye movement sleep behavior disorder symptoms correlate with domains of cognitive impairment in Parkinson’s disease

J.R. Zhang, J. Chen, Z.J. Yang, H.J. Zhang, Y.T. Fu, Y. Shen, P.C. He, C.J. Mao, C.F. Liu (Suzhou, People's Republic of China)

12:00pm-1:30pm: Reliability of verbal and written trail test for individuals with Parkinson’s disease: Is it a good cognitive test?

M.R. Olchik, M. Ghisi, A. Freiry, A.F.S. Schuh, C.R.M. Rieder (Porto Alegre, Brazil)

12:00pm-1:30pm: Response inhibition in Parkinson’s disease

J. Kim, K. Zhang, M.A.I.U.A. Cruadhlaoich, S. YorkWilliams, V. Menon, K.L. Poston (Stanford, CA, USA)

12:00pm-1:30pm: Retrieval action verbs is impaired in Parkinson´s disease patients using a sentence completion task

E. Herrera, R. Pérez, M. González-Nosti (Gijón, Spain)

12:00pm-1:30pm: Scores and dimensions to assess cognitive impairment in Parkinson’s disease

I. Liepelt-Scarfone, S. Gräber, A. Pilotto, D. Blum, M. Fruhmann Berger, D. Berg (Tübingen, Germany)

12:00pm-1:30pm: Screening of posterior cortical dysfunction in early Parkinson’s disease with mild cognitive impairment as an approach to select patients at higher risk for developing dementia

H. Bejr-Kasem, J. Pagonabarraga, R. Fernandez-Bobadilla, J. Perez-Perez, J. Marin-Lahoz, B. Pascual-Sedano, S. Martínez-Horta, J. Kulisevsky (Barcelona, Spain)

12:00pm-1:30pm: Self-reported cognitive complaints and neuropsychological performance in idiopathic REM sleep behavior disorder

P.A. Bourgouin, F. Escudier, L. Bernier-Lalonger, R.B. Postuma, J. Montplaisir, J.F. Gagnon (Montreal, QC, Canada)

12:00pm-1:30pm: Sensitivity of people with Parkinson’s to different intensities of emotions (SPiEs)

J. Wincenciak, D.J. Burn, L.S. Delicato (Newcastle upon Tyne, United Kingdom)

12:00pm-1:30pm: Single-subject FDG PET patterns and cognitive dysfunctions in Parkinson’s disease

A. Pilotto, E. Premi, S.P. Caminiti, L. Presotto, R. Turrone, A. Alberici, B. Paghera, B. Borroni, D. Perani, A. Padovani (Brescia, Italy)

12:00pm-1:30pm: Speech prosody impairment predicts cognitive decline in Parkinson’s disease

I. Rektorova, J. Mekyska, E. Janousova, M. Kostalova, M. Mrackova, I. Eliasova, D. Berankova, R. Marecek (Brno, Czech Republic)

12:00pm-1:30pm: Staging of cognitive impairment: Validation of a novel cognitive score with [¹⁸F]FDG-PET

D. Blum, M. Reimold, W. Maetzler, C. la Fougère, G. Reischl, D. Berg, I. Liepelt-Scarfone (Tübingen, Germany)

12:00pm-1:30pm: Synaptic biomarkers for cognitive decline in Lewy body dementias and Alzheimer’s disease. A mass spectrometry approach

E. Bereczki, R.M.M. Branca, P.T. Francis, J.H. Baek, J. Lehtio, D. Aarsland (Huddinge, Sweden)

12:00pm-1:30pm: Temporal working memory deficit in Parkinson’s disease

B. Degos, I. Ameqrane, S. Rivaud-Péchoux, P. Pouget, M. Missal (Paris, France)

12:00pm-1:30pm: The alterations in behavioral memory for prolongation disease duration in patients with Parkinson’s disease

M. Saruwatari, Y. Kobayashi, A. Kumon, K. Hasegawa (Sagamihara, Japan)

12:00pm-1:30pm: The cognitive profile of idiopathic REM sleep behavior disorder

L. Bernier-Lalonger, F. Escudier, P.A. Bourgouin, R.B. Postuma, J. Montplaisir, J.F. Gagnon (Montreal, QC, Canada)

12:00pm-1:30pm: The effect of anodal transcranial direct current stimulation (tDCS) on sequential motor skill learning in persons with Parkinson’s disease

E. Kerckhofs, N. Deroost (Brussels, Belgium)

12:00pm-1:30pm: The effect of statin use on cognition in Parkinson’s disease

B.L. Deck, J. Rick, S.X. Xie, A. Chen-Plotkin, J.E. Duda, J.F. Morley, L.M. Chahine, N. Dahodwala, R.S. Akhtar, J.Q. Trojanowski, D. Weintraub (Philadelphia, PA, USA)

12:00pm-1:30pm: The effects of deep brain stimulation for Parkinson’s disease on cognition and perceived quality of life: Preliminary results from an Ecuadorian sample

M.B. Jurado Noboa, R. Santibañez Vásquez, J. Achi, M. Navarrete, C. Mawyin (Guayaquil, Ecuador)

12:00pm-1:30pm: The relationship between cognitive aspects (education status, executive function and verbal fluency) and motor aspects (balance and gait) in patients with Parkinson’s disease

C.O. Souza, M.C. Voos, H.F. Chien, D.V. Francato, A.F. Barbosa, J.M. Greve, E.T. Fonoff, E.R. Barbosa (Sao Paulo, Brazil)

12:00pm-1:30pm: The role of neuroinflammation in the development of Parkinson’s disease dementia

A. Kouli, R. Vuono, R.A. Barker, C.H. Williams-Gray (Cambridge, United Kingdom)

12:00pm-1:30pm: Transcranial sonography and cognitive dysfunction in Parkinson’s disease

S. Behnke, A. Pilotto, I. Liepelt-Scarfone, R. Yilmaz, C. Pausch, S. Dieterich, I. Posner, J. Spiegel, U. Dillmann, M. Unger, B. Schmidl, J. Bürmann, K. Fassbender, D. Berg (Homburg Saar, Germany)

12:00pm-1:30pm: Treatment and diagnosis with the use of neuropsychological scale in patients with posttraumatic subcortical Parkinsonian dementia

R.R. Umarov, N.G. Sokhibnazarov (Tashkent, Uzbekistan)

12:00pm-1:30pm: Treatment with the use of the PD-specific scales for patients suffering from subcortical Parkinsonian dementia

N.G. Sokhibnazarov, F.K. Shermukhamedova (Tashkent, Uzbekistan)

12:00pm-1:30pm: Unilateral subthalamotomy in Parkinson´s disease: Cognitive and neuropsychiatric effects and correlation with lesion size

I. Obeso, E. Casabona, R. Rodríguez-Rojas, N. Pavón, R. Macías, M.L. Bringas, J.A. Obeso, M. Jahanshahi (Madrid, Spain)

12:00pm-1:30pm: Use of dementia rating scale-II (DRS-II) total score in PD deep brain stimulation (DBS) candidacy determination

M.J. Sollman, J.G. Hesse, B.C. Sachs, J.F. Cook (Winston-Salem, NC, USA)

12:00pm-1:30pm: Validation of the Seoul-instrumental activity of daily living in the detection of dementia in Parkinson’s disease

S.J. Kim, E.J. Chung (Busan, Korea)

12:00pm-1:30pm: Visual hallucinations may serve as a possible predictor for Parkinson’s disease dementia

Y.P. Chang, Y.H. Yang, C.L. Lai, L.M. Liou (Kaohsiung, Taiwan)

« View all sessions from the 20th International Congress.